The role of molecular chaperonins in warm ischemia and reperfusion injury in the steatotic liver: A proteomic study
- Venkataswarup Tiriveedhi1, 6Email author,
- Kendra D Conzen1,
- Jane Liaw-Conlin1,
- Gundumi Upadhya1,
- James Malone2,
- R Reid Townsend2, 3,
- Robnet Kerns2,
- Jianluo Jia1,
- Krista Csontos2,
- Sabarinathan Ramachandran1,
- Thallachallour Mohanakumar1, 4,
- Christopher D Anderson5 and
- William C Chapman1, 7Email author
© Tiriveedhi et al.; licensee BioMed Central Ltd. 2012
Received: 30 June 2012
Accepted: 5 September 2012
Published: 10 September 2012
The molecular basis of the increased susceptibility of steatotic livers to warm ischemia/reperfusion (I/R) injury during transplantation remains undefined. Animal model for warm I/R injury was induced in obese Zucker rats. Lean Zucker rats provided controls. Two dimensional differential gel electrophoresis was performed with liver protein extracts. Protein features with significant abundance ratios (p < 0.01) between the two cohorts were selected and analyzed with HPLC/MS. Proteins were identified by Uniprot database. Interactive protein networks were generated using Ingenuity Pathway Analysis and GRANITE software.
The relative abundance of 105 proteins was observed in warm I/R injury. Functional grouping revealed four categories of importance: molecular chaperones/endoplasmic reticulum (ER) stress, oxidative stress, metabolism, and cell structure. Hypoxia up-regulated 1, calcium binding protein 1, calreticulin, heat shock protein (HSP) 60, HSP-90, and protein disulfide isomerase 3 were chaperonins significantly (p < 0.01) down-regulated and only one chaperonin, HSP-1was significantly upregulated in steatotic liver following I/R.
Down-regulation of the chaperones identified in this analysis may contribute to the increased ER stress and, consequently, apoptosis and necrosis. This study provides an initial platform for future investigation of the role of chaperones and therapeutic targets for increasing the viability of steatotic liver allografts.
KeywordsIschemia repurfusion injury Two dimensional gel electrophoresis Mass spectrometry Liver transplantation Chaperonins Endoplasmic reticulum (ER) stress
Approximately 6,000 liver transplants are performed annually in the United States (U.S. Scientific Registry and Transplant Recipients 2008). The shortage of available organs, remains a major problem and contributes to a waiting list mortality greater than 110 deaths per 1000 patient years on the waiting list . The current donor shortage is further compounded by the increasing prevalence of hepatic steatosis in potential donors. Fatty infiltration of the liver is now the most common adverse condition in potential donors, with a prevalence of 13-50% in some populations [2, 3]. Steatotic livers are more susceptible to ischemia/reperfusion (I/R) injury induced by both warm and cold ischemic periods during transplantation, which directly lead to higher rates of primary nonfunction and delayed graft function [4–6]. Initial primary nonfunction predisposes to three-fold increased incidence of early rejection and graft loss within three months of transplantation . The severity of I/R injury is associated with the degree of fatty infiltration. Severely steatotic livers (>60% steatosis) are contraindicated for liver transplantation [5, 6]. Although, moderate steatosis (30-60%) is a relative contraindication for transplantation, however, due to the limited availability of the organs, these allografts are also being used with greater frequency in several transplant centers .
Efforts have been made to understand the molecular mechanisms responsible for poor graft function in steatotic livers. However, research to date has been limited by focus on individual pathways or molecules. Given the numerous intracellular changes which are likely to occur, a global molecular approach is required to identify mediators of injury. Proteomics provides one approach to identify and study potential biomarkers and mediators and offers the advantage of elucidating overall patterns of injury-induced changes at the protein level, including both changes in relative protein abundance and post-translational modifications of proteins [8, 9]. Proteomics has been successfully employed in the study of various liver injury models and models of ischemia/reperfusion (I/R) [10–15]. High levels of oxidative stress and decreased levels of antioxidant proteins have been implicated as important mediators of injury due to ethanol-induced steatosis . Steatosis has been implicated to induce changes in the mitochondrial proteome . The I/R injury in other organs is shown to increase mitochondrial permeability, contributing to activation of apoptotic pathways . Studies have demonstrated that proteins and enzymes involved in lipid and energy metabolism, redox signaling and oxidative stress responses were affected during cold and warm I/R phases in transplantation . Despite research into the mechanisms of injury in liver I/R and in steatosis, a comprehensive study on the proteome in liver subjected to I/R has not yet been studied. Therefore, we performed a proteomic analysis on fatty rat livers following a period of warm ischemia to identify potential mediators of ischemia/reperfusion injury.
Male obese (n = 3) and lean (control group, n = 3) Zucker rats were purchased from Harlan Laboratories (Indianapolis, IN). Upon arrival at the pathogen-free barrier facility at Washington University in St. Louis, rats weighed 280 to 310 grams and were 8–11 weeks old. Animals had access to standard chow ad libitum and were maintained on a 12 h light-dark cycle. Animal protocols were approved by the Animal Studies Committee of Washington University in St. Louis and experiments were performed in accordance with the National Institutes of Health Guidelines for the Use of Laboratory Animals.
A model of selective (70%) hepatic warm ischemia was used. Anesthesia was induced with 3% inhaled isoflurane and maintained with 1.5 - 2% isoflurane. Animals were placed on a warming table and the abdominal wall was shaved and sterilized with betadine. Laparotomy was performed through a midline incision. The portal triad was dissected free of surrounding tissue. Portal vein and hepatic artery branches to the left and median hepatic lobes were identified and occluded with a microvascular clamp for 45 min (Fine Science Tools, Foster City, CA). This method of partial hepatic ischemia prevents mesenteric venous congestion and permits decompression of the gut through the right hepatic vessels. Observed blanching of the left and median hepatic lobes confirmed appropriate placement of the clamp. The abdomen was covered with saline-moistened gauze during ischemia. Upon portal clamp removal, evidence of reperfusion was observed through immediate color change of the left and median lobes. The abdominal wall was closed with a running 4–0 monofilament suture. After 1 h of reperfusion, a median lobectomy was performed by ligation of the median lobe portal pedicle with a 4–0 silk suture. The left lobe was removed in a similar manner after two hours of reperfusion. All tissue samples were snap frozen in liquid nitrogen and stored at-80°C until processing.
The sample preparation for two-dimensional differential gel electrophoresis was performed with liver protein extracts as previously described . Individual pieces of frozen liver tissue (approximately 1 cm2) from lean or obese animals were covered with liquid nitrogen in a pre-cooled Biopulverizer (Biospec Products Inc., Bartsville, OK) and crushed to a fine powder. Each sample was solubilized in lysis buffer (Tris-HCl pH 8.5 (30 mM), 7 M urea, 2 M thiourea, and 4% CHAPS), and the total protein content was determined using the Advanced Protein Assay (Cytoskeleton, Inc.). A total pool was generated using equal amounts of each pool to represent all proteins found in the study. An aliquot containing 50 μg of protein from each sample was diluted to 50μL with lysis buffer (Tris-HCl pH 8.5 (30 mM), 7 M urea, 2 M thiourea, and 4% CHAPS) and labeled with 400 pmol of charge-matched cyanine dyes (GE health care, Pittsburgh, PA) 3-[(4-carboxymethyl) phenylmethyl]-3-ethyloxacarbocyanine halide N-hydroxysuccinimidyl ester (Cy2,) for lean, or 1-(5-carboxypentyl)-10-methylindodicarbocyanine halide N-hydroxysuccinimidyl ester (Cy5) for obese. All chemicals unless otherwise specified were obtained from Sigma-Aldrich (St. Louis, MO). The total pool sample was labeled using 1-(5-carboxypentyl)-10-propylindocarbocyanine halide N- hydroxysuccinimidyl ester (Cy3) for combined protein pool as internal standard for intergel comparison. The pool consisted of all 3 samples and was prepared by combining 50 μg of each individual sample. All labeling reactions were carried out for 45 min at 4°C and protected from light. The reaction was quenched with 10 nmol of lysine for 10 min (4°C, protected from light). Labeled lean and obese samples were combined with a total pool aliquot and the resulting mixture was diluted by addition of 300 mL of rehydration buffer (7 M urea/2 M thiourea, 4% CHAPS, 0.5% v/v ampholytes (pH 3–10)) .
Two dimensional electrophoresis (2-de) and imaging
Each combined tripartite-labeled sample (450 μL final volume) was rehydrated into 24 cm, 3–10 NL IPG strips (GE Healthcare, Piscataway, NJ) under low voltage (100 V) for 12 h, followed by isoelectric focusing (IEF) using a Protean IEF cell (Bio-Rad Labs, Hercules, CA) for a total of 65.5 kVh (using a three-step voltage protocol: 500 V and held for 500 Vh, 1000 V and held for 1000 Vh, 8000 V, and held for 64,000 Vh). After focusing, proteins were reduced by placing the IPG strips in 10 mL of equilibration buffer (10 mL, 50 mM Tris (pH 8.8), 6 M urea, 30% glycerol, 2% SDS, bromophenol blue) containing freshly prepared DTT (50 mg) for 15 min at room temperature. The proteins were then alkylated by adding iodoacetamide (600 mg in 10 mL of equilibration buffer). IPG strips were then rinsed with 1X SDS running buffer (25 mM Tris, 192 mM glycine, 0.1% SDS) and layered on 10-20% polyacrylamide gels and sealed with agarose (1% w/v in 16x running buffer). Commercially prepared gels (Jule, Inc., Milford, CT) were cast between low-fluorescence glass plates using bind-silane (GE Healthcare, Piscataway, NJ) to attach the gel to one plate as per the manufacturer’s instructions. Second-dimension SDS-PAGE separation was carried out on all gels simultaneously using 5 W/gel for the first 15 min followed by 1 W/gel for 17 h with circulating buffer (20°C) in the lower buffer chamber. Images of the labeled proteins in each gel were generated using a Typhoon Imager (GE Healthcare, Piscataway, NJ) and the following excitation/emission wavelengths for each dye (488/520 nm for Cy2, 520/580 nm for Cy3, and 620/670 nm for Cy5). After image generation, the nonsilanized glass plate was removed and the gels were placed in fixing solution (33% ethanol, 7.5% acetic acid) for 2 h. Gels were then rinsed with deionized water (18 MΩ) for 15 min and stored in water-filled, sealed bags at 47°C. All steps were performed to minimize exposure to ambient light.
Gel image analysis
Protein features with significant abundance ratios (fold-change) between experimental groups (p < 0.01) were selected by gel image analysis (DeCyder v. 6.5) and analyzed with high performance liquid chromatography (HPLC)/mass spectometry (MS). ImageQuant (Molecular Dynamics from GE Healthcare, Piscataway, NJ) software was used to crop the gel images and remove portions of the image corresponding to the IPG strip, the spacers between the gel plates, and any remaining dye front from the electrophoresis. The DeCyder (v. 6.5) DIA (difference in-gel analysis) module was used to identify gel feature boundaries and calculate abundance ratios using a normalization algorithm that was applied as previously described [22–24]. Standard parameters were used to determine boundaries estimating 10,000 features per image. Gel artifacts were removed by software from each gel image using a peak volume filter set at 10,000. Additional gel artifacts (e.g. water spots, dust particles) were excluded manually. Images were compared across multiple gels using the DeCyder BVA (Biological Variation Analysis) module. This analysis matched features in the pool images from each gel, using this sample as a quantitative reference for protein features in the remaining images allowing quantitative comparison of features in all images in the experiment. The DeCyder Extended Data Analysis (EDA) module was used to perform t-test analysis and generate heatmaps. Matched features with significant differences in abundance ratios (p <0.01) or with abundance ratios > 1.5 (p < 0.05) and 100% gel presence were selected for further analysis.
Gel digestion, preparation of peptides and mass spectrometric analysis
Selected features were excised robotically (ProPic, Genomic Solutions, Ann Arbor, MI) using a triangulation algorithm implemented with in-house software. Proteins in the gel pieces were digested in situ with trypsin , and stored at −80°C until analyzed by mass spectrometry. Samples were analyzed using a nanoflow (200 nl/min) pulse-free liquid chromatograph, interfaced to a quadrupole time-of-flight mass spectrometer (Q-STAR XL, Applied Biosystems, Foster City, CA) using a PicoView system (New Objective, Woburn, MA), or nano-reversed-phase HPLC interfaced to an electrospray-linear ion trap-Fourier transform ion cyclotron mass spectrometer (LTQ-FT, Thermo-Finnigan, Ringoes, NJ) operated as previously described . The MS and MS/MS data were collected in the profile mode. The “raw” files were processed using MASCOT Distiller, version 184.108.40.206 (Matrix Science, Oxford, U.K.) and searched using MASCOT version 2.3.02 against the UniProt Rat database (downloaded November 21, 2011) with 41, 601 entries (Additional file 1: Table S1). The resulting DAT files were imported into Scaffold, ver. 3.5.1 (Proteome Software, Portland, OR) to identify proteins with greater than or equal to 95% confidence and to determine the spectral counts for each protein. The detailed mass spectrometry and peptide data are summarized in Additional file 1: Table S1.
Network and pathway analysis
Proteins identified from the Uniprot database were imported into Ingenuity Pathway Analysis (IPA) software, version 6.3 (Ingenuity Systems,Inc., Redwood city, CA) to generate interactive protein networks. Duplicate GI numbers were manually removed prior to loading. GI numbers were loaded into IPA; proteins not recognized by IPA were removed from analysis. A network analysis was performed with limitations set at 35 proteins; direct and indirect relationships were permitted. Core analysis of the protein set generated, producing 9 interactome networks.
Gene networks were created by submitting gene symbol lists to the GRANITE web application (Gene RelAtional Network of InTeracting Elements), a tool to generate gene relational networks (http://bioinformatics.wustl.edu/webTools/GraniteGeneSearch.do). The “enhanced” GRANITE function was used to discover genes not present in but are targets of or interact with submitted gene sets. Gene sets combined with any discovered genes were reloaded into GRANITE to complete connections from discovered genes to genes in the original list. Raw and filtered GRANITE output was directly loaded into Cytoscape for network integeration and visualization .
Identification of protein targets in warm I/R injury
Identification of the differentially regulated proteins by mass spectrometry
The 84 features of interest identified by ANOVA analysis on the 2-DE were excised subjected to in-gel digestion with trypsin, and the peptide pools from each excised feature were analyzed using nano-LC-MS, as described under ‘Materials and Methods’. The database searches were qualified using the Protein Prophet algorithm (95% protein probability) within the SCAFFOLD software. The analysis identified 106 proteins with 453 peptides in the 84 ‘differential’ features (see Additional file 2: Table S2 for peptide sequences and supporting MS data). These lead protein targets were utilized for further analysis to identify the biochemical pathways involved in the I/R injury.
Differential expression of ER stress related molecular chaperones in steatotic liver after I/R compared to lean liver
Ingenuity pathway analysis identifies four molecular chaperone mediated pathways as the critical targets of I/R injury
The recent genomic revolution has resulted in a paradigm drift in the comprehensive analysis of biological processes and biochemical regulators. A continuous body of literature strongly indicating a non-predictive correlation between mRNA and protein level expression , along with posttranscriptional modifications leading to control in the rate of synthesis and half-life of proteins place  an increased importance on the direct measurement of the protein expression by proteomic techniques to analyze the biochemical signaling pathways. In this report using various proteomics based approaches we determine the key role of regulatory molecular chaperonins in the I/R injury in the setting of liver steatosis.
The demand for liver allografts remains a challenging problem for transplant centers in the US and across the globe, especially with the increasing prevalence of hepatic steatosis in the donor population . Attenuation of steatosis-associated ischemia/reperfusion injury is an important strategy for reducing allograft shortages. Proteomic analysis is an important tool for large-scale analysis of cellular changes induced through various injury models, including that of hepatic ischemia . This particular analysis revealed that the proteome profile of steatotic liver following a period of warm ischemia/reperfusion significantly differs from that of lean liver. Some functional groups, such as those involved with amino acid metabolism, fatty acid metabolism, and cellular structure, are expected to be significantly different in steatotic liver, regardless of I/R injury. A novel finding, however, was the significant down-regulation of multiple molecular chaperones. Chaperonins have important roles in protein folding and structure . Disruptions in cellular homeostasis can cause perturbations in protein processing, resulting in an accumulation of unfolded proteins. This triggers the “unfolded protein response” (UPR), or endoplasmic reticulum (ER stress) response, a response to cellular stress which can lead to adaptation or trigger apoptotic pathways . Chaperonins reduce ER stress by stabilizing proteins which become unfolded during periods of cellular stress (e.g., I/R). Pdia3 encodes ERp57, a known molecular chaperone with well-established interactions with calreticulin and their role in antigen-processing/loading of MHC class I molecules [33, 34]. ERp57 is also known to regulate Grp78, a key molecular chaperone in initiating one of three ER stress signaling cascades . The chaperonin subset of proteins, with these molecules in particular, represent potential therapeutic targets for mitigating I/R injury.
The Akt pathway, a serine/threonine kinase, has been shown to play an important role in various types of ischemia/reperfusion. Although it did not show significant differential expression at the reperfusion time points analyzed in our study, Akt is indirectly related to multiple chaperonins which do play a significant role in protein folding and processing, and have implicated roles in endoplasmic reticulum stress in other models. Akt has also been shown to play a role in ER stress. Given these relationships which we have identified, it is likely that ER stress plays a role in the greater injury sustained by steatotic liver following intervals of ischemia/reperfusion . Also, certain key mediators of the unfolded protein response (Grp78, IRE-1a, XBP-1(s), ATF4, and CHOP) are shown to be upregulated in both a murine model of hepatic warm I/R and a rat liver transplant model .
The potential role of chaperones as drug targets has been well established. Previous studies in our laboratory using a chaperones targeting small chemical molecule, taurine-conjugated ursodeoxycholic acid (TUDCA), has shown to decrease ER stress response and decrease ischemia repurfusion injury in animal models of steatotic liver allografts . The role of chaperones in ischemia injury has also been established in other transplant models such as cardiac myocytes . Not just limited to transplant settings, but in other disease states such as malaria, chaperones are considered as important drug targets . However, in our initial study along with chaperones/ER stress protein group we have also identified other protein groups such as oxidative stress, metabolism, and cell structure. Although, it is currently unclear of their potential role in drug targeting these protein groups in ameliorating I/R injury and enhancing survival of steatotic liver allografts, future research on these protein groups could offer novel molecular targets.
Certain inherent limitations with 2-DE based proteomics approaches associated with artifacts and database subset mapping in identifying exact target proteins  warrants further direct cell based functional studies to validate our current findings. Lean liver tissue served as the comparison, or control, for steatotic liver subjected to warm ischemia and a short period of reperfusion; however, it might be revealing to compare these samples to liver tissue not subject to I/R. Samples obtained at additional reperfusion times would help establish a trend in protein expression profiles. In spite of limitations we still consider our current study to add new insights and further research to study the functional basis and potential chaperonin-based therapeutic strategies to enhance long term survival of the liver allografts.
In conclusion, using a broad-based proteome analysis, we identified key differences between ischemic responses in steatotic and lean livers. Down-regulation of the chaperonins identified in this analysis may contribute to the increased levels of endoplasmic reticulum stress and, consequently, apoptosis and necrosis observed in steatotic livers compared to lean livers. The proteins identified in this report, provide an initial platform for investigating the role of molecular chaperones in I/R injury in fatty liver and provide potential therapeutic targets for increasing viability of steatotic liver allografts.
This work was supported by grants from the NIH National Center for Research Resources P01 HL66196-01(WCC); P41 RR00954 and UL1 RR024992 (RRT); and NIH 5T32CA00962120 (KDC). The NIH did not play a role in study design; in the collection, analysis, and interpretation of data; in the writing of the manuscript; or in the decision to submit the paper for publication. The authors thank Petra Erdmann-Gilmore and Alan E. Davis for expert technical assistance and for performing the LC-MS analysis.
- U.S. Scientific Registry of Transplant Recipients: 2008 Annual Report of the US organ pocurement and Transplantation network and the Scietific Registry of Transplant Recipients: Transplant data 1998–2007. 2008, U.S. Department of Health and Human Resources, Division of Transplantation, RockvilleGoogle Scholar
- Trevisani F, Colantoni A, Caraceni P, Van Thiel DH: The use of donor fatty liver for liver transplantation: a challenge or a quagmire?. J Hepatol. 1996, 24 (1): 114-121.PubMedView ArticleGoogle Scholar
- Halon A, Patrzalek D, Rabczynski J: Hepatic steatosis in liver transplant donors: rare phenomenon or common feature of donor population?. Transplant Proc. 2006, 38 (1): 193-195. 10.1016/j.transproceed.2005.11.088.PubMedView ArticleGoogle Scholar
- Todo S, Demetris AJ, Makowka L, Teperman L, Podesta L, Shaver T, Tzakis A, Starzl TE: Primary nonfunction of hepatic allografts with preexisting fatty infiltration. Transplantation. 1989, 47 (5): 903-905. 10.1097/00007890-198905000-00034.PubMedPubMed CentralView ArticleGoogle Scholar
- Selzner M, Clavien PA: Fatty liver in liver transplantation and surgery. Semin Liver Dis. 2001, 21 (1): 105-113. 10.1055/s-2001-12933.PubMedView ArticleGoogle Scholar
- Ploeg RJ, D'Alessandro AM, Knechtle SJ, Stegall MD, Pirsch JD, Hoffmann RM, Sasaki T, Sollinger HW, Belzer FO, Kalayoglu M: Risk factors for primary dysfunction after liver transplantation–a multivariate analysis. Transplantation. 1993, 55 (4): 807-813. 10.1097/00007890-199304000-00024.PubMedView ArticleGoogle Scholar
- Strasberg SM, Howard TK, Molmenti EP, Hertl M: Selecting the donor liver: risk factors for poor function after orthotopic liver transplantation. Hepatology. 1994, 20 (4 Pt 1): 829-838.PubMedView ArticleGoogle Scholar
- Edwards AV, White MY, Cordwell SJ: The role of proteomics in clinical cardiovascular biomarker discovery. Mol Cell Proteomics. 2008, 7 (10): 1824-1837. 10.1074/mcp.R800007-MCP200.PubMedView ArticleGoogle Scholar
- Ping P: Getting to the heart of proteomics. N Engl J Med. 2009, 360 (5): 532-534. 10.1056/NEJMcibr0808487.PubMedPubMed CentralView ArticleGoogle Scholar
- Avellini C, Baccarani U, Trevisan G, Cesaratto L, Vascotto C, D'Aurizio F, Pandolfi M, Adani GL, Tell G: Redox proteomics and immunohistology to study molecular events during ischemia-reperfusion in human liver. Transplant Proc. 2007, 39 (6): 1755-1760. 10.1016/j.transproceed.2007.05.082.PubMedView ArticleGoogle Scholar
- Emadali A, Muscatelli-Groux B, Delom F, Jenna S, Boismenu D, Sacks DB, Metrakos PP, Chevet E: Proteomic analysis of ischemia-reperfusion injury upon human liver transplantation reveals the protective role of IQGAP1. Mol Cell Proteomics. 2006, 5 (7): 1300-1313. 10.1074/mcp.M500393-MCP200.PubMedView ArticleGoogle Scholar
- Eismann T, Huber N, Shin T, Kuboki S, Galloway E, Wyder M, Edwards MJ, Greis KD, Shertzer HG, Fisher AB: Peroxiredoxin-6 protects against mitochondrial dysfunction and liver injury during ischemia-reperfusion in mice. Am J Physiol Gastrointest Liver Physiol. 2009, 296 (2): G266-274.PubMedPubMed CentralView ArticleGoogle Scholar
- Hirsch J, Hansen KC, Choi S, Noh J, Hirose R, Roberts JP, Matthay MA, Burlingame AL, Maher JJ, Niemann CU: Warm ischemia-induced alterations in oxidative and inflammatory proteins in hepatic Kupffer cells in rats. Mol Cell Proteomics. 2006, 5 (6): 979-986. 10.1074/mcp.M500320-MCP200.PubMedView ArticleGoogle Scholar
- Svetlov SI, Xiang Y, Oli MW, Foley DP, Huang G, Hayes RL, Ottens AK, Wang KK: Identification and preliminary validation of novel biomarkers of acute hepatic ischaemia/reperfusion injury using dual-platform proteomic/degradomic approaches. Biomarkers. 2006, 11 (4): 355-369. 10.1080/13547500600775110.PubMedView ArticleGoogle Scholar
- Xu C, Zhang X, Yu C, Lu G, Chen S, Xu L, Ding W, Shi Q, Li Y: Proteomic analysis of hepatic ischemia/reperfusion injury and ischemic preconditioning in mice revealed the protective role of ATP5beta. Proteomics. 2009, 9 (2): 409-419. 10.1002/pmic.200800393.PubMedView ArticleGoogle Scholar
- Newton BW, Russell WK, Russell DH, Ramaiah SK, Jayaraman A: Liver proteome analysis in a rodent model of alcoholic steatosis. J Proteome Res. 2009, 8 (4): 1663-1671. 10.1021/pr800905w.PubMedPubMed CentralView ArticleGoogle Scholar
- Douette P, Navet R, Gerkens P, De Pauw E, Leprince P, Sluse-Goffart C, Sluse FE: Steatosis-induced proteomic changes in liver mitochondria evidenced by two-dimensional differential in-gel electrophoresis. J Proteome Res. 2005, 4 (6): 2024-2031. 10.1021/pr050187z.PubMedView ArticleGoogle Scholar
- Weiss JN, Korge P, Honda HM, Ping P: Role of the mitochondrial permeability transition in myocardial disease. Circ Res. 2003, 93 (4): 292-301. 10.1161/01.RES.0000087542.26971.D4.PubMedView ArticleGoogle Scholar
- Vascotto C, Cesaratto L, D'Ambrosio C, Scaloni A, Avellini C, Paron I, Baccarani U, Adani GL, Tiribelli C, Quadrifoglio F: Proteomic analysis of liver tissues subjected to early ischemia/reperfusion injury during human orthotopic liver transplantation. Proteomics. 2006, 6 (11): 3455-3465. 10.1002/pmic.200500770.PubMedView ArticleGoogle Scholar
- Bredemeyer AJ, Lewis RM, Malone JP, Davis AE, Gross J, Townsend RR, Ley TJ: A proteomic approach for the discovery of protease substrates. Proc Natl Acad Sci U S A. 2004, 101 (32): 11785-11790. 10.1073/pnas.0402353101.PubMedPubMed CentralView ArticleGoogle Scholar
- Gorg A, Obermaier C, Boguth G, Harder A, Scheibe B, Wildgruber R, Weiss W: The current state of two-dimensional electrophoresis with immobilized pH gradients. Electrophoresis. 2000, 21 (6): 1037-1053. 10.1002/(SICI)1522-2683(20000401)21:6<1037::AID-ELPS1037>3.0.CO;2-V.PubMedView ArticleGoogle Scholar
- Alban A, David SO, Bjorkesten L, Andersson C, Sloge E, Lewis S, Currie I: A novel experimental design for comparative two-dimensional gel analysis: two-dimensional difference gel electrophoresis incorporating a pooled internal standard. Proteomics. 2003, 3 (1): 36-44. 10.1002/pmic.200390006.PubMedView ArticleGoogle Scholar
- Unlu M, Morgan ME, Minden JS: Difference gel electrophoresis: a single gel method for detecting changes in protein extracts. Electrophoresis. 1997, 18 (11): 2071-2077. 10.1002/elps.1150181133.PubMedView ArticleGoogle Scholar
- Karp NA, Kreil DP, Lilley KS: Determining a significant change in protein expression with DeCyder during a pair-wise comparison using two-dimensional difference gel electrophoresis. Proteomics. 2004, 4 (5): 1421-1432. 10.1002/pmic.200300681.PubMedView ArticleGoogle Scholar
- Havlis J, Thomas H, Sebela M, Shevchenko A: Fast-response proteomics by accelerated in-gel digestion of proteins. Anal Chem. 2003, 75 (6): 1300-1306. 10.1021/ac026136s.PubMedView ArticleGoogle Scholar
- King JB, Gross J, Lovly CM, Rohrs H, Piwnica-Worms H, Townsend RR: Accurate mass-driven analysis for the characterization of protein phosphorylation. Study of the human Chk2 protein kinase. Anal Chem. 2006, 78 (7): 2171-2181. 10.1021/ac051520l.PubMedView ArticleGoogle Scholar
- Shannon P, Markiel A, Ozier O, Baliga NS, Wang JT, Ramage D, Amin N, Schwikowski B, Ideker T: Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res. 2003, 13 (11): 2498-2504. 10.1101/gr.1239303.PubMedPubMed CentralView ArticleGoogle Scholar
- Gygi SP, Rochon Y, Franza BR, Aebersold R: Correlation between protein and mRNA abundance in yeast. Mol Cell Biol. 1999, 19 (3): 1720-1730.PubMedPubMed CentralView ArticleGoogle Scholar
- Varshavsky A: The N-end rule: functions, mysteries, uses. Proc Natl Acad Sci U S A. 1996, 93 (22): 12142-12149. 10.1073/pnas.93.22.12142.PubMedPubMed CentralView ArticleGoogle Scholar
- Wertheim JA, Petrowsky H, Saab S, Kupiec-Weglinski JW, Busuttil RW: Major challenges limiting liver transplantation in the United States. Am J Transplant. 2011, 11 (9): 1773-1784. 10.1111/j.1600-6143.2011.03587.x.PubMedPubMed CentralView ArticleGoogle Scholar
- Fink AL: Chaperone-mediated protein folding. Physiol Rev. 1999, 79 (2): 425-449.PubMedGoogle Scholar
- Szegezdi E, Logue SE, Gorman AM, Samali A: Mediators of endoplasmic reticulum stress-induced apoptosis. EMBO Rep. 2006, 7 (9): 880-885. 10.1038/sj.embor.7400779.PubMedPubMed CentralView ArticleGoogle Scholar
- Vyas JM, Van der Veen AG, Ploegh HL: The known unknowns of antigen processing and presentation. Nat Rev Immunol. 2008, 8 (8): 607-618. 10.1038/nri2368.PubMedPubMed CentralView ArticleGoogle Scholar
- Hughes EA, Hammond C, Cresswell P: Misfolded major histocompatibility complex class I heavy chains are translocated into the cytoplasm and degraded by the proteasome. Proc Natl Acad Sci U S A. 1997, 94 (5): 1896-1901. 10.1073/pnas.94.5.1896.PubMedPubMed CentralView ArticleGoogle Scholar
- Ni M, Lee AS: ER chaperones in mammalian development and human diseases. FEBS Lett. 2007, 581 (19): 3641-3651. 10.1016/j.febslet.2007.04.045.PubMedPubMed CentralView ArticleGoogle Scholar
- Cai Z, Semenza GL: PTEN activity is modulated during ischemia and reperfusion: involvement in the induction and decay of preconditioning. Circ Res. 2005, 97 (12): 1351-1359. 10.1161/01.RES.0000195656.52760.30.PubMedView ArticleGoogle Scholar
- Ben Mosbah I, Alfany-Fernandez I, Martel C, Zaouali MA, Bintanel-Morcillo M, Rimola A, Rodes J, Brenner C, Rosello-Catafau J, Peralta C: Endoplasmic reticulum stress inhibition protects steatotic and non-steatotic livers in partial hepatectomy under ischemia-reperfusion. Cell Death Dis. 2010, 1: e52-10.1038/cddis.2010.29.PubMedView ArticleGoogle Scholar
- Anderson CD, Upadhya G, Conzen KD, Jia J, Brunt EM, Tiriveedhi V, Xie Y, Ramachandran S, Mohanakumar T, Davidson NO: Endoplasmic reticulum stress is a mediator of posttransplant injury in severely steatotic liver allografts. Liver Transpl. 2011, 17 (2): 189-200. 10.1002/lt.22220.PubMedPubMed CentralView ArticleGoogle Scholar
- Schett G, Metzler B, Kleindienst R, Amberger A, Recheis H, Xu Q, Wick G: Myocardial injury leads to a release of heat shock protein (hsp) 60 and a suppression of the anti-hsp65 immune response. Cardiovasc Res. 1999, 42 (3): 685-695. 10.1016/S0008-6363(99)00012-7.PubMedView ArticleGoogle Scholar
- Pesce ER, Cockburn IL, Goble JL, Stephens LL, Blatch GL: Malaria heat shock proteins: drug targets that chaperone other drug targets. Infect Disord Drug Targets. 2010, 10 (3): 147-157.PubMedView ArticleGoogle Scholar
- Gygi SP, Corthals GL, Zhang Y, Rochon Y, Aebersold R: Evaluation of two-dimensional gel electrophoresis-based proteome analysis technology. Proc Natl Acad Sci U S A. 2000, 97 (17): 9390-9395. 10.1073/pnas.160270797.PubMedPubMed CentralView ArticleGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.